​

Cosmos Health Stock (NASDAQ:COSM)

RevenueOwnershipFinancialsChart
Cosmos Health by TradingView

Previous Close

$0.21

52W Range

$0.20 - $1.32

50D Avg

$0.31

200D Avg

$0.55

Market Cap

$13.04M

Avg Vol (3M)

$1.51M

Beta

4.12

Div Yield

-

COSM Company Profile

Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

149

IPO Date

Jul 23, 2010

Website

COSM Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Pharma manufacturing$1.69M$865.37K-
Nutraceuticals and Pharmaceuticals$4.26M--
Wholesale$59.32M--
Other---

Fiscal year ends in Dec 25 | Currency in USD

COSM Financial Summary

Dec 25Dec 24Dec 23
Revenue$65.27M$54.43M$53.38M
Operating Income$-16.70M$-15.54M$-21.83M
Net Income$-19.14M$-16.18M$-18.54M
EBITDA$-15.33M$-13.92M$-17.06M
Basic EPS$-0.63$-1.17$-2.15
Diluted EPS$-0.63$-1.17$-2.15

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
LSTALisata Therapeutics, Inc.
NCNANuCana plc
MTVAMetaVia Inc.
NXGLNEXGEL, Inc.
FEMYFemasys Inc.
SCYXSCYNEXIS, Inc.
PASGPassage Bio, Inc.
IINNInspira Technologies Oxy B.H.N. Ltd.
CLSDClearside Biomedical, Inc.